NRXS
NeurAxis, Inc.NASDAQHealthcare$7.25+2.21%ClosedMarket Cap: $81.1M
As of 2026-04-04
Valuation
P/E (TTM)
—
PEG
—
P/B
19.80
P/S
23.23
EV/EBITDA
-10.22
DCF Value
$-3.98
FCF Yield
-7.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
84.2%
Operating Margin
-219.4%
Net Margin
-218.5%
ROE
-306.0%
ROA
-121.8%
ROIC
-204.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $968.1K | 85.4% | $-1.7M | $-1.7M | $-0.16 | — |
| FY 2025 | $3.6M | 84.2% | $-7.8M | $-7.8M | $-0.95 | — |
| Q3 2025 | $811.4K | 83.3% | $-2.1M | $-2.1M | $-0.24 | — |
| Q2 2025 | $894.1K | 83.6% | $-1.7M | $-1.7M | $-0.22 | — |
| Q1 2025 | $895.7K | 84.4% | $-2.3M | $-2.3M | $-0.33 | — |
| Q4 2024 | $761.2K | 86.2% | $-1.5M | $-1.4M | $-0.24 | — |
| FY 2024 | $2.7M | 86.5% | $-7.2M | $-8.2M | $-1.22 | — |
| Q3 2024 | $666.6K | 85.4% | $-1.7M | $-1.8M | $-0.25 | — |
| Q2 2024 | $611.5K | 88.0% | $-2.2M | $-2.9M | $-0.42 | — |
| Q1 2024 | $646.6K | 88.4% | $-1.8M | $-2.1M | $-0.32 | — |
| Q4 2023 | $531.5K | 86.4% | $-1.6M | $-5.3M | $-0.84 | — |
| FY 2023 | $2.5M | 87.7% | $-6.7M | $-14.6M | $-2.32 | — |